Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Plasma PAI-1 levels are independently related to fatty liver and hypertriglyceridemia in familial combined hyperlipidemia, involvement of apolipoprotein E.

Thrombosis research - 1 Jan 2008

Brouwers Martijn C G J, Govers-Riemslag Jose, Schalkwijk Casper G, van Greevenbroek Marleen M J, van der Kallen Carla J H, Bekers Otto, van Dieijen-Visser Marja P, Ten Oever Jaap, Bilderbeek-Beckers Monique A L, de Bruin Tjerk W A, Ten Cate Hugo, Stehouwer Coen D A

Abstract excerpt

BACKGROUND: Familial combined hyperlipidemia (FCHL) is a genetic form of dyslipidemia, which is characterized by an increased cardiovascular risk. The current study was conducted to investigate the relation of endothelial, inflammatory and fibrinolysis markers with the presence of hypertriglyceridemia and fatty liver in FCHL, in order to advance insight in their contribution to the cardiovascular risk profile....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apolipoproteins E
Share to Cardiovascular Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fatty Liver

Share to Gene Expression Regulation

Share to Hyperlipidemias

Share to Hypertriglyceridemia

Share to Inflammation

Share to Plasminogen Activator Inhibitor 1

Source

Identifiers

PMID: 18262228
DOI: 10.1016/j.thromres.2007.12.009

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Plasma PAI-1 levels are independently related to fatty liver and hypertriglyceridemia in familial combined hyperlipidemia, involvement of apolipoprotein E.PMID 18262228Read ↗

Fatty liver--based identification of two distinct hypertriglyceridemic subgroups in familial combined hyperlipidemia.Semantic proximity Read ↗

Familial combined hyperlipidemia: An overview of the underlying molecular mechanisms and therapeutic strategiesSemantic proximity Read ↗

Familial hypercholesterolemia and lipoprotein(a) hyperlipidemia as independent and combined cardiovascular risk factors.Semantic proximity Read ↗

Genetics of familial combined hyperlipidemia.Semantic proximity Read ↗

Molecular mechanisms, prevalence, and molecular methods for familial combined hyperlipidemia disease: A reviewSemantic proximity Read ↗

Familial hypertriglyceridemia: an entity with distinguishable features from other causes of hypertriglyceridemia.Semantic proximity Read ↗

Familial Hypertriglyceridemia: An Entity with Distinguishable Features from other Causes of HypertriglyceridemiaSemantic proximity Read ↗

Combined hyperlipidemia: familial but not (usually) monogenic.Semantic proximity Read ↗

Unraveling the complex genetics of familial combined hyperlipidemia.Semantic proximity Read ↗

Metabolic disorders and inflammation are associated with familial combined hyperlipemia.Semantic proximity Read ↗

Relationship between apolipoprotein E polymorphism, postprandial hyperlipemia and hemostatic variables in patients with combined hyperlipemia.Semantic proximity Read ↗

Genetics of familial combined hyperlipidemia and risk of coronary heart disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.